The Endocrine Society has unveiled a comprehensive strategic framework designed to fortify the global endocrine research community, centering its efforts on the critical pillars of presentation, publication, and mentorship. This multi-faceted approach comes at a pivotal moment for the scientific community, as researchers navigate a complex landscape characterized by fluctuating federal funding and the rapid evolution of open-access publishing. By expanding financial support for its flagship annual meeting and refining its professional development pipelines, the Society aims to bridge the gap between basic laboratory discovery and clinical application, ensuring that the next generation of endocrine scientists possesses the resources necessary to address pressing global health challenges.
As the world’s oldest and largest organization devoted to research on hormones and the clinical practice of endocrinology, the Society represents a diverse membership of more than 18,000 professionals. The newly emphasized initiatives reflect a conscious effort to support the "bench" side of the "bench-to-bedside" continuum, acknowledging that the foundational work of basic scientists is the prerequisite for all medical breakthroughs. Central to this mission is the upcoming ENDO 2026 conference, scheduled to take place in Chicago, Illinois, from June 13 to June 16, 2026. This event serves as the primary nexus for the exchange of endocrine knowledge, and the Society has taken unprecedented steps to ensure that financial barriers do not prevent promising researchers from contributing to this global dialogue.
Strategic Expansion of Travel Grant Programs
In a significant move approved unanimously by the Board of Directors, the Endocrine Society has authorized a one-year expansion of its travel grant programs specifically for the ENDO 2026 cycle. This initiative is designed to counteract the rising costs of international and domestic travel, which have increasingly strained the budgets of academic laboratories. By providing substantial additional financial support, the Society is facilitating a more inclusive environment where researchers from diverse geographic and socioeconomic backgrounds can present their findings.
The importance of this expansion is underscored by the scale of the ENDOExpo, the Society’s premier exhibition hall. Each year, the expo features more than 2,500 abstracts, representing the cutting edge of hormone research. These poster sessions are more than just static displays; they are dynamic networking hubs where junior researchers can engage with established icons in the field. To further amplify the reach of this research, the Society has integrated modern digital communication strategies. Selected members who submit abstracts are invited to participate in video interviews, which are then disseminated across the Society’s social media platforms. In previous years, these videos have garnered thousands of views, providing researchers with a level of visibility that extends far beyond the physical confines of the conference center.
The decision to increase funding for 2026 is also a response to the broader economic climate. Data from various scientific advocacy groups suggest that while total research funding may remain stable in some sectors, the purchasing power of individual grants has been eroded by inflation and the rising costs of specialized laboratory equipment. By subsidizing travel, the Endocrine Society is effectively protecting the "human capital" of the research enterprise—the scientists themselves.
Advancing Research Through High-Impact Publishing
A critical component of the Society’s support structure is its robust publishing ecosystem. For over a century, the Endocrine Society has been at the forefront of scientific communication, with its suite of journals documenting the most significant milestones in the field since 1917. The current publishing strategy emphasizes accessibility and research integrity, ensuring that high-quality data is available to the global scientific community without delay.
One of the primary benefits for researchers presenting at the annual meeting is the opportunity to have their abstracts published in a dedicated supplement of the Journal of the Endocrine Society (JES). This open-access journal ensures that research is not only visible but also citable. Every abstract is assigned a unique Digital Object Identifier (DOI), a permanent link that allows the work to be referenced in future studies and tracked via academic metrics. This process provides early-career researchers with an essential "footprint" in the scholarly record.
Beyond conference abstracts, the Society’s broader journal portfolio—which includes prestigious titles such as Endocrinology and The Journal of Clinical Endocrinology & Metabolism—continues to set the standard for the field. Members benefit from reduced production costs for accepted manuscripts, a tangible financial incentive that encourages the submission of high-quality work to Society-owned outlets. The peer-review process remains a cornerstone of this effort. Each submission undergoes rigorous scrutiny by recognized thought leaders, with a steadfast commitment to research integrity and transparency. In an era where "predatory" publishing and data replication issues have become concerns, the Society’s adherence to the strictest editorial standards provides a necessary safeguard for the credibility of endocrine science.
Mentorship and the Professional Development Pipeline
Recognizing that the future of the field depends on the successful transition of students into independent investigators, the Endocrine Society has invested heavily in two flagship mentorship programs: the Research Experiences for Graduate and Medical Students (REGMS) and the Future Leaders Advancing Research in Endocrinology (FLARE) program.
The REGMS program is specifically designed to identify and nurture talent at the earliest stages of professional development. By offering graduate and medical students the opportunity to engage in collaborative lab work and receive expert mentorship, the program helps build the foundational skills required for a career in research. Participants are not merely passive observers; they are integrated into professional networks and participate in year-round activities that enhance their technical and soft skills. The application review process for the current cycle is already underway, reflecting the high demand for such structured career support.
Parallel to REGMS is the FLARE program, which targets a slightly more advanced demographic, including graduate students, postdoctoral fellows, clinical fellows, and junior faculty. FLARE is distinguished by its focus on leadership and the practicalities of establishing an independent research career. Participants receive specialized training in grant writing, lab management, and navigating the complexities of academic institutional politics. The upcoming FLARE workshop, scheduled for late March, is a cornerstone of this initiative. Past participants have frequently cited the program as a turning point in their careers, providing them with the confidence and the professional "roadmap" necessary to secure independent funding and lead their own research teams.
Specialized Knowledge Development and the Basic Science Summit
In addition to broad mentorship, the Endocrine Society continues to provide highly specialized educational opportunities that cater to the niche interests of basic scientists. The upcoming Basic Science Summit on Nuclear Receptors, to be held in Chicago this fall, exemplifies this commitment. Nuclear receptors play a fundamental role in how cells respond to hormones, and they are key targets for a wide array of pharmacological interventions. By hosting a focused summit, the Society allows for a deep dive into molecular mechanisms that might be overlooked in a more general clinical setting.
The educational programming at the annual ENDO meeting also reflects this commitment to technical excellence. Sessions are designed to cover the full spectrum of the field, from the latest CRISPR-Cas9 applications in endocrine research to the nuances of metabolic signaling. This continuous learning model ensures that members remain at the cutting edge of technological and theoretical advancements.
Broader Impact and Implications for Global Health
The Society’s emphasis on supporting researchers is not merely an internal professional goal; it has profound implications for public health. Endocrine-related disorders, including diabetes, obesity, thyroid disease, and osteoporosis, affect hundreds of millions of people worldwide. The "research pipeline" that the Society is working to strengthen is the same pipeline that produces new insulin delivery systems, more effective hormone replacement therapies, and innovative treatments for endocrine-disrupting chemical exposures.
The current global funding climate for science is characterized by intense competition. In the United States, for instance, the National Institutes of Health (NIH) "paylines"—the percentile score a grant must receive to be funded—have remained historically tight. In such an environment, the professional support provided by a scientific society can be the difference between a researcher staying in the field or leaving for other industries. By providing travel grants, publishing discounts, and mentorship, the Endocrine Society is effectively acting as a stabilizer for the endocrine workforce.
Furthermore, the focus on international participation and open-access publishing ensures that scientific progress is a global endeavor. Researchers in low- and middle-income countries often face significant barriers to accessing the latest research and attending international conferences. The Society’s initiatives, particularly the DOI-assigned open-access abstracts and the expansion of travel support, help to democratize scientific knowledge and foster international collaboration.
Conclusion
The Endocrine Society’s strategic focus on Presenting, Publishing, and Mentorship represents a holistic commitment to the health of the scientific enterprise. By investing in the people who perform the research, the Society is ensuring that the field of endocrinology remains vibrant, innovative, and capable of solving the hormone-related health challenges of the future. As the organization prepares for the 2026 Chicago meeting and continues its year-round advocacy and education efforts, its role as a central pillar of the global research community appears more vital than ever. The unified support of the Board of Directors and the active engagement of the membership suggest a clear path forward: one where scientific discovery is prioritized, and the next generation of leaders is empowered to succeed.